With More than 27 Years of Experience Leading Companies in the Medical Imaging, Software and Medical Device Space, Koeniguer Brings Extensive Commercial Expertise.
First-Ever Breast Center Installation Including a Mobile Mammography System Highlights Volpara Solutions’ Tremendous Growth in 2015
RSNA Research Shows VolparaDensity Central to Quantifying Masking Risk and Optimizing Adjunctive Imaging
Nine Abstracts Accepted for Presentation at RSNA 2015 Demonstrate Benefit of Volpara Solutions Industry Leading Suite of Volumetric Breast Imaging Tools
Volpara Solutions Introduces New Additions to Its Market-Leading Breast Density Assessment and Enterprise Analytics Portfolio at RSNA
CHICAGO, November 30, 2015 – Volpara Solutions today introduced two new additions to its industry-leading suite of automated breast density assessment and enterprise analytics solutions, here at the 101st Annual Radiological...
Volpara Awarded New FDA Clearance for Automated Breast Density Assessment Correlating to BI-RADS 5th Edition Categories
WELLINGTON, New Zealand, November 9, 2015 – Volpara Solutions, the leading provider of automated breast density assessment and quantitative breast imaging tools, announced today that it has received a new...
Dutch Researchers Compare BI-RADS 5th Edition Breast Density Scores to Automated Volumetric Breast Density in a Clinical Setting
Volpara Density Grades from Volpara Solutions Showed Substantial Agreement with Visual BI-RADS 5th Edition Scores
Volpara Solutions Announces 3-Year Contract with Premier for its Industry Leading Breast Density Assessment and Analytics Tools
Thousands of Premier Members to Have Access to Preferred Pricing for VolparaDensity and Volpara’s Full Suite of Quantitative Breast Imaging Tools
With Lower Variability than Area-Based Methods, Volumetric Density Well Suited for Inclusion in Breast Cancer Risk Models, According to Study Featured in RADIOLOGY
VolparaDensity Used to Guide Patient Selection in First Breast MRI Screening Trial for Women with Extremely Dense Breasts
VolparaDensity Used to Guide Patient Selection in First Breast MRI Screening Trial for Women with Extremely Dense Breasts Design of Randomized-Controlled DENSE Trial Featured in RADIOLOGY
Bolsters Commercial Team with Deep Sales and Marketing Experience in the United States and Worldwide